Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multi-centre, randomised, double-blind, parallel group study assessing the efficacy and safety of IV nesiritide versus placebo, in addition to background care, in the treatment of subjects with acute decompensated heart failure. Evaluating Treatment with Nesiritide in Acute Decompensated Heart Failure (ETNA)

Next Previous
X
Search
Trial Profile

A multi-centre, randomised, double-blind, parallel group study assessing the efficacy and safety of IV nesiritide versus placebo, in addition to background care, in the treatment of subjects with acute decompensated heart failure. Evaluating Treatment with Nesiritide in Acute Decompensated Heart Failure (ETNA)

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Decompensated heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms ETNA
  • Sponsors GlaxoSmithKline Research & Development; GSK; Janssen-Cilag

    • Most Recent Events

    • 22 Dec 2021 This trial has been completed in Belgium, according to European Clinical Trials Database record.
    • 25 Jun 2019 This trial has been completed in Ireland, according to European Clinical Trials Database.
    • 05 Jun 2019 This trial has been discontinued in United Kingdom, according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top